Innospec (IOSP) to Release Quarterly Earnings on Thursday

Innospec (NASDAQ:IOSP) will release its earnings data after the market closes on Thursday, May 9th. Analysts expect Innospec to post earnings of $1.63 per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Innospec (NASDAQ:IOSP) last announced its quarterly earnings data on Tuesday, February 13th. The specialty chemicals company reported $1.84 earnings per share for the quarter, beating analysts’ consensus estimates of $1.59 by $0.25. The company had revenue of $494.70 million for the quarter, compared to analysts’ expectations of $479.47 million. Innospec had a return on equity of 13.69% and a net margin of 7.14%. Innospec’s revenue for the quarter was down 3.1% compared to the same quarter last year. During the same period last year, the firm posted $1.20 EPS. On average, analysts expect Innospec to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Innospec Trading Up 0.5 %

Shares of NASDAQ IOSP opened at $124.96 on Wednesday. The stock’s 50-day moving average is $123.98 and its 200 day moving average is $117.23. Innospec has a 1-year low of $91.74 and a 1-year high of $131.18. The stock has a market cap of $3.12 billion, a price-to-earnings ratio of 22.43 and a beta of 1.11.

Insider Buying and Selling

In other news, SVP David B. Jones sold 2,500 shares of Innospec stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $125.79, for a total value of $314,475.00. Following the sale, the senior vice president now directly owns 9,664 shares in the company, valued at approximately $1,215,634.56. The sale was disclosed in a filing with the SEC, which is available through this link. In other Innospec news, SVP David B. Jones sold 2,500 shares of Innospec stock in a transaction on Friday, March 1st. The stock was sold at an average price of $125.79, for a total transaction of $314,475.00. Following the completion of the transaction, the senior vice president now owns 9,664 shares in the company, valued at $1,215,634.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Leslie J. Parrette purchased 410 shares of the firm’s stock in a transaction dated Thursday, February 22nd. The stock was acquired at an average price of $123.96 per share, with a total value of $50,823.60. Following the purchase, the director now directly owns 3,620 shares of the company’s stock, valued at $448,735.20. The disclosure for this purchase can be found here. Insiders have sold a total of 36,500 shares of company stock worth $4,532,959 in the last ninety days. 1.35% of the stock is owned by insiders.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.